aica ribonucleotide has been researched along with Acute Lymphoid Leukemia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Barredo, JC; Beckedorff, F; Leclerc, GJ; Li, B; Shiekhattar, R; Shvab, A; Sun, G | 1 |
| Chen, Y; Du, L; Fang, H; Li, H; Sun, H; Xu, Y; Yang, F; Zheng, L; Zhou, BS | 1 |
| Heyer, CL; Moran, RG; Racanelli, AC; Rothbart, SB | 1 |
| Barredo, JC; Kuznetsov, JN; Leclerc, GJ; Leclerc, GM | 1 |
| Fleming, RM; Hrafnsdóttir, S; Magnúsdóttir, M; Paglia, G; Palsson, BØ; Thiele, I; Thorlacius, S | 1 |
| Haile, WH; McGuire, JJ; Yeh, CC | 1 |
| Barredo, JC; Hsieh-Kinser, TT; Leclerc, GJ; Leclerc, GM; Sengupta, TK; Singh, I | 1 |
7 other study(ies) available for aica ribonucleotide and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Protein Kinase D-Dependent Downregulation of Immediate Early Genes through Class IIA Histone Deacetylases in Acute Lymphoblastic Leukemia.
Topics: Aminoimidazole Carboxamide; Animals; Apoptosis; Cell Line, Tumor; DNA Damage; Down-Regulation; Enzyme Activation; HEK293 Cells; HeLa Cells; Histone Deacetylases; Humans; Jurkat Cells; Mice; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Promoter Regions, Genetic; Protein Kinase C; Protein Serine-Threonine Kinases; Ribonucleotides; Signal Transduction | 2021 |
AICAr suppresses cell proliferation by inducing NTP and dNTP pool imbalances in acute lymphoblastic leukemia cells.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; CRISPR-Cas Systems; Deoxyribonucleotides; DNA Breaks, Double-Stranded; DNA Replication; Drug Screening Assays, Antitumor; Gene Knockout Techniques; Genes, p53; Genes, rRNA; Humans; Nucleotides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Ribonucleotides; RNA, Ribosomal; Transcription, Genetic; Tumor Suppressor Protein p53; Uridine | 2019 |
Therapeutics by cytotoxic metabolite accumulation: pemetrexed causes ZMP accumulation, AMPK activation, and mammalian target of rapamycin inhibition.
Topics: Adenylate Kinase; Aminoimidazole Carboxamide; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Division; Enzyme Activation; Folic Acid Antagonists; Glutamates; Glycine; Guanine; Humans; Kinetics; Lung Neoplasms; Mesothelioma; Pemetrexed; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinases; Ribonucleotides; TOR Serine-Threonine Kinases | 2009 |
AMPK and Akt determine apoptotic cell death following perturbations of one-carbon metabolism by regulating ER stress in acute lymphoblastic leukemia.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Apoptosis; Carbon; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Endoplasmic Reticulum; Humans; Methotrexate; Molecular Targeted Therapy; Phosphorylation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-akt; Ribonucleotides; Signal Transduction | 2011 |
Monitoring metabolites consumption and secretion in cultured cells using ultra-performance liquid chromatography quadrupole-time of flight mass spectrometry (UPLC-Q-ToF-MS).
Topics: Aminoimidazole Carboxamide; Biphenyl Compounds; Cell Line, Tumor; Chromatography, High Pressure Liquid; Chromatography, Liquid; Humans; Mass Spectrometry; Metabolomics; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Purines; Pyrimidines; Pyrones; Reproducibility of Results; Ribonucleotides; Thiophenes | 2012 |
5-amino-4-imidazolecarboxamide riboside potentiates both transport of reduced folates and antifolates by the human reduced folate carrier and their subsequent metabolism.
Topics: Aminoimidazole Carboxamide; Biological Transport; Cell Line, Tumor; Child; Dose-Response Relationship, Drug; Drug Synergism; Folic Acid Antagonists; Humans; Kinetics; Leukemia, T-Cell; Membrane Transport Proteins; Methotrexate; Phosphoribosylglycinamide Formyltransferase; Polyglutamic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reduced Folate Carrier Protein; Ribonucleotides; Subcellular Fractions; Temperature; Thymidylate Synthase; Tritium | 2006 |
Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Antineoplastic Agents; Apoptosis; Cell Division; DNA Replication; Drug Delivery Systems; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Enzyme Activation; G1 Phase; Humans; Imidazoles; Leukemia-Lymphoma, Adult T-Cell; Multienzyme Complexes; Neoplasm Proteins; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prodrugs; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Pyridines; Ribonucleotides; Sirolimus; Tubercidin; Tumor Cells, Cultured | 2007 |